Table 2.
Mortality risk of patients according to RT-PCR for SARS-CoV-2 test result: positive, negative or pending
| Positivea | Negativeb | Pending-resultc | ||||
|---|---|---|---|---|---|---|
| Crude model | Adjusted model | Crude model | Adjusted model | Crude model | Adjusted model | |
| Obesity model | ||||||
| Without comorbidities | Reference | |||||
| Obesity alone | 2.37 (1.96–2.86) | 2.47 (2.04–2.98) | 1.18 (0.81–1.73) | 1.05 (0.71–1.53) | 1.79 (0.89–3.61) | 1.73 (0.86–3.48) |
| DM model | ||||||
| Without comorbidities | Reference | |||||
| DM alone | 3.66 (2.99–4.49) | 1.91 (1.55–2.35) | 5.92 (4.46–7.85) | 2.99 (2.22–4.03) | 3.17 (1.58–6.38) | 1.74 (0.85–3.59) |
| Obesity alone | 2.36 (1.95–2.84) | 2.42 (2.01–2.93) | 1.18 (0.81–1.73) | 1.05 (0.72–1.54) | 1.79 (0.89–3.61) | 1.71 (0.85–3.44) |
| DM + obesity | 3.88 (2.85–5.29) | 2.79 (2.04–3.80) | 3.78 (2.07–6.92) | 2.33 (1.27–4.29) | 1.91 (0.46–7.92) | 1.60 (0.38–6.68) |
| COPD model | ||||||
| Without comorbidities | Reference | |||||
| COPD alone | 5.92 (3.64–9.64) | 1.72 (1.05–2.84) | 11.98 (8.23–17.44) | 3.05 (1.97–4.72) | 1.95 (0.27–14.24) | 0.58 (0.08–4.44) |
| Obesity alone | 2.36 (1.96–2.86) | 2.47 (2.04–2.99) | 1.18 (0.81–1.73) | 1.05 (0.72–1.54) | 1.79 (0.89–3.61) | 1.74 (0.86–3.49) |
| COPD + obesity | 4.29 (1.60–11.5) | 2.42 (0.89–6.53) | 5.84 (1.45–23.5) | 1.80 (0.44–7.64) | 9.86 (1.35–72.01) | 5.13 (0.68–38.59) |
| Asthma model | ||||||
| Without comorbidities | Reference | |||||
| Asthma alone | 0.35 (0.13–0.96) | 0.63 (0.24–1.70) | 0.49 (0.22–1.11) | 0.57 (0.25–1.29) | 0.83 (0.14–6.05) | 1.40 (0.19–10.37) |
| Obesity alone | 2.37 (1.96–2.86) | 2.47 (2.04–2.99) | 1.18 (0.81–1.72) | 1.04 (0.71–1.53) | 1.80 (0.89–3.62) | 1.72 (0.85–3.46) |
| Asthma + obesity | 1.42 (0.59–3.45) | 2.18 (0.90–5.28) | 1.63 (0.61–4.39) | 1.81 (0.67–4.87) | Not estimable | |
| Immunosuppression model | ||||||
| Without comorbidities | Reference | |||||
| Immunosupp. alone | 3.04 (1.75–5.28) | 2.54 (1.46–4.43) | 5.96 (4.05–8.77) | 5.22 (3.54–7.70) | 4.13 (1.27–13.41) | 2.71 (0.79–9.27) |
| Obesity alone | 2.36 (1.96–2.86) | 2.45 (2.03–2.97) | 1.18 (0.81–1.73) | 1.05 (0.72–1.54) | 1.79 (0.89–3.61) | 1.69 (0.84–3.40) |
| Immunosupp. + obesity | 5.62 (2.51–12.6) | 5.06 (2.26–11.41) | 6.33 (2.03–19.79) | 4.64 (1.49–14.55) | 37.6 (5.11–276.44) | 34.63 (4.48–267.43) |
| Hypertension model | ||||||
| Without comorbidities | Reference | |||||
| Hypertension alone | 2.98 (2.45–3.65) | 1.33 (1.08–1.64) | 3.31 (2.48–4.41) | 1.39 (1.03–1.89) | 2.38 (1.19–4.78) | 1.15 (0.55–2.39) |
| Obesity alone | 2.37 (1.96–2.86) | 2.46 (2.03–2.97) | 1.18 (0.81–1.73) | 1.04 (0.71–1.53) | 1.78 (0.88–3.57) | 1.72 (0.85–3.45) |
| Hypertension + obesity | 3.44 (2.64–4.48) | 2.30 (1.77–3.01) | 2.43 (1.48–3.97) | 1.34 (0.82–2.21) | 2.25 (0.81–6.31) | 1.49 (0.53–4.22) |
| CVD model | ||||||
| Without comorbidities | Reference | |||||
| CVD alone | 3.55 (2.05–6.18) | 2.00 (1.15–3.48) | 4.75 (2.47–8.14) | 2.89 (1.66–5.02) | 2.75 (0.95–11.64) | 1.57 (0.34–7.21) |
| Obesity alone | 2.37 (1.96–2.86) | 2.47 (2.04–2.98) | 1.18 (0.81–1.73) | 1.05 (0.72–1.53) | 1.79 (0.89–3.59) | 1.69 (0.84–3.40) |
| CVD + obesity | 2.82 (0.70–11.3) | 1.44 (0.36–5.78) | 7.82 (2.91–21.02) | 4.33 (1.59–11.72) | 7.53 (1.03–55.03) | 4.87 (0.55–43.34) |
| CKD model | ||||||
| Without comorbidities | Reference | |||||
| CKD alone | 1.77 (0.66–4.76) | 1.24 (0.46–3.34) | 6.81 (3.51–13.26) | 3.55 (1.80–6.98) | 8.07 (1.95–33.46) | 5.79 (1.34–24.89) |
| Obesity alone | 2.37 (1.96–2.86) | 2.47 (2.04–2.98) | 1.18 (0.81–1.73) | 1.05 (0.72–1.53) | 1.79 (0.89–3.61) | 1.74 (0.86–3.50) |
| CKD + obesity | 2.69 (0.38–19.2) | 4.63 (0.65–33.1) | 10.37 (2.57–41.71) | 6.24 (1.55–25.19) | 15.96 (2.18–116.79) | 10.35 (1.39–76.83) |
95% CI, 95% confidence interval; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; DM, diabetes mellitus; HR, hazard ratio; Immunosupp, immunosuppression.
Data are presented as HR (95% CI).
Model adjusted by sex, age and time from symptom onset to care, SLI, ageing index, afro-descendant per 100 inhabitants, indigenous language-speaking per 100 inhabitants, affiliation to health services per 100 inhabitants, members per household, hospitals per 10 000 inhabitants, hospital beds per 10 000 inhabitants.
Model adjusted by sex, age and time from symptom onset to care, SLI, ageing index, afro-descendant per 100 inhabitants, indigenous language-speaking per 100 inhabitants, affiliation to health services per 100 inhabitants, members per household, hospitals per 10 000 inhabitants, hospital beds per 10 000 inhabitants.
Model adjusted by sex, age, smoking and time from symptom onset to care, SLI, ageing index, afro-descendant per 100 inhabitants, indigenous language-speaking per 100 inhabitants, affiliation to health services per 100 inhabitants, members per household, hospitals per 10 000 inhabitants, hospital beds per 10 000 inhabitants.